• Home
  • News
    • Editorial
    • MD(e)B(unker)
    • Related Researches
      • Di Bella's Foundation
      • 1960-1969
      • 1970-1979
      • 1980-1989
      • 1990-1999
      • 2000-2009
      • 2010-2019
      • 2020-2029
    • Science news
    • Scientific Documentation
  • About us...
    • Biography
    • Bibliography
  • The Method
    • Di Bella's Method!
    • 1998 Trial!
  • Media
    • Video Publications
    • News-PapersNews-Papers
      • Press
    • TestimonialTestimonial
      • Testimonies
    • Video GalleryVideo Gallery
      • Congresses
      • Video Testimonies
      • TV & C.
  • Case History
    • Medical reports
      • Lung
      • Lymphomas
        • Non-Hodgkin Lymphomas
        • Hodgkin Lymphomas
      • Mediastinum
      • Mesothelioma
      • Myeloma
      • Pancreas
      • Scientific Publications
  • F.A.Q.
  • Useful Links
    • User Side
      • Vademecum
    • CouponChief - Resources for Cancer Patients
  • Contact Us
Home page   Case History   Medical reports  
Title Created Date
Malignant pleural mesothelioma, stage T3-T4 - Consideration of a case study 18 May 2014
Mesothelioma: case report, treated exclusively with DBM for over 4 years 04 April 2014
Pleural Mesothelioma: clinical records on 11 patients 14 October 2013
Display # 

Search

Follow us...

Latest

  • Vitamin D and Cancer: An Historical Overview of the Epidemiology and Mechanisms
  • Oxidative stress enhances rotavirus oncolysis in breast cancer and leukemia, except in melanoma with abundant matrix
  • Polystyrene nanoplastic exposure induces excessive mitophagy by activating AMPK/ULK1 pathway in differentiated SH-SY5Y cells and dopaminergic neurons in vivo
  • Reduced melatonin levels may facilitate glioblastoma initiation in the subventricular zone
  • Breast cancer survivals and hormone therapy: estrogen and melatonin
  • Melatonin and Related Compounds: Antioxidant and Anti-Inflammatory Actions
  • Perspectives in pineal functions
  • Dose-Dependency of Antitumor Effects of the Pineal Hormone Melatonin in Untreatable Metastatic Solid Tumor Patients
  • Effect of melatonin on the cytotoxicity of chemotherapeutic drugs in human leukemia cells
  • Melatonin attenuates estradiol-induced oxidative damage to DNA: relevance for cancer prevention
  • Melatonin in the treatment of cancer: a systematic review of randomized controlled trials and meta-analysis
  • Melatonin cytotoxicity in human leukemia cells: relation with its pro-oxidant effect
  • Enhancement of the efficacy of cancer chemotherapy by the pineal hormone melatonin and its relation with the psychospiritual status of cancer patients
  • The Role of Dopamine in Repurposing Drugs for Oncology
  • GHRH Antagonist Causes DNA Damage Leading to p21 Mediated Cell Cycle Arrest and Apoptosis in Human Colon Cancer Cells
  • Melatonin and cancer: From the promotion of genomic stability to use in cancer treatment
  • Immunological role and prognostic value of somatostatin receptor family members in colon adenocarcinoma
  • Molecular Mechanism of Vitamin D Receptor Modulating Wnt/β-catenin Signaling Pathway in Gastric Cancer

Most Read

  • The Di Bella Method (DBM)
  • All-trans-retinoic acid and cancer
  • About melatonin - 1996
  • Biography
  • The Di Bella Method Increases by the 30% the survival rate for Pancreas tumors and for this reason should be proposed as first line therapy for this type of cancer
  • Chronic Lymphocytic Leukemia: 4 patients, long-lasting remission
  • Somatostatin in oncology, the overlooked evidences
  • Bibliography
  • Large B-cells Non-Hodgkin's Lymphoma, Stage IV-AE: a Case Report
  • Non-Hodgkin's Lymphoma, Stage III-B-E: a Case Report
  • How effective is chemo therapy?
  • Vademecum
  • Complete objective response to biological therapy of plurifocal breast carcinoma
  • Treatment of Low-grade Non-Hodgkin’s Lymphomas at Advanced Stage
  • Frequently Asked Questions
  • Declaration recommends eliminate the use of Impact factor for research evaluation
  • Malignant pleural mesothelioma, stage T3-T4 - Consideration of a case study
  • Non–Small-Cell Lung Cancer Patients with Low Performance Status: study on 28 patients